Ameriprise’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.46M Sell
173,175
-279,509
-62% -$8.81M ﹤0.01% 2283
2025
Q1
$14.8M Buy
452,684
+2,423
+0.5% +$79.4K ﹤0.01% 1504
2024
Q4
$16.3M Sell
450,261
-95,794
-18% -$3.46M ﹤0.01% 1472
2024
Q3
$17M Sell
546,055
-18,356
-3% -$572K ﹤0.01% 1424
2024
Q2
$15.1M Sell
564,411
-1,859
-0.3% -$49.7K ﹤0.01% 1453
2024
Q1
$19.3M Buy
566,270
+6,568
+1% +$224K 0.01% 1318
2023
Q4
$16.2M Sell
559,702
-9,317
-2% -$270K ﹤0.01% 1399
2023
Q3
$15.7M Sell
569,019
-26,206
-4% -$722K 0.01% 1380
2023
Q2
$17.9M Sell
595,225
-83,614
-12% -$2.51M 0.01% 1333
2023
Q1
$24.6M Sell
678,839
-19,451
-3% -$705K 0.01% 1127
2022
Q4
$24.9M Sell
698,290
-95,267
-12% -$3.4M 0.01% 1087
2022
Q3
$26.9M Sell
793,557
-31,503
-4% -$1.07M 0.01% 995
2022
Q2
$23.9M Sell
825,060
-22,255
-3% -$644K 0.01% 1098
2022
Q1
$27.4M Buy
847,315
+21,987
+3% +$711K 0.01% 1117
2021
Q4
$24.1M Sell
825,328
-14,190
-2% -$414K 0.01% 1277
2021
Q3
$22.4M Buy
839,518
+36,277
+5% +$967K 0.01% 1183
2021
Q2
$24.7M Buy
803,241
+38,264
+5% +$1.18M 0.01% 1197
2021
Q1
$20M Buy
764,977
+9,923
+1% +$260K 0.01% 1329
2020
Q4
$19M Buy
755,054
+64,316
+9% +$1.62M 0.01% 1255
2020
Q3
$14.4M Buy
690,738
+52,493
+8% +$1.09M 0.01% 1291
2020
Q2
$15.2M Sell
638,245
-145,047
-19% -$3.44M 0.01% 1235
2020
Q1
$14.1M Buy
783,292
+23,283
+3% +$419K 0.01% 1156
2019
Q4
$18M Buy
760,009
+129,434
+21% +$3.07M 0.01% 1269
2019
Q3
$17.3M Sell
630,575
-61,383
-9% -$1.69M 0.01% 1246
2019
Q2
$22.9M Buy
691,958
+248,525
+56% +$8.22M 0.01% 1064
2019
Q1
$15.5M Sell
443,433
-36,404
-8% -$1.28M 0.01% 1325
2018
Q4
$15.9M Buy
479,837
+21,463
+5% +$713K 0.01% 1209
2018
Q3
$23.1M Sell
458,374
-90,891
-17% -$4.58M 0.01% 1190
2018
Q2
$32.9M Sell
549,265
-40,170
-7% -$2.4M 0.01% 870
2018
Q1
$27M Sell
589,435
-11,119
-2% -$509K 0.01% 960
2017
Q4
$23.9M Sell
600,554
-81,238
-12% -$3.24M 0.01% 957
2017
Q3
$27.3M Buy
681,792
+102,341
+18% +$4.09M 0.01% 864
2017
Q2
$25M Sell
579,451
-34,968
-6% -$1.51M 0.01% 877
2017
Q1
$19.2M Sell
614,419
-283,962
-32% -$8.89M 0.01% 1044
2016
Q4
$22.7M Buy
898,381
+9,316
+1% +$235K 0.01% 917
2016
Q3
$22M Sell
889,065
-23,675
-3% -$586K 0.01% 879
2016
Q2
$18.6M Buy
912,740
+134,544
+17% +$2.74M 0.01% 950
2016
Q1
$11.9M Buy
778,196
+34,755
+5% +$530K 0.01% 1287
2015
Q4
$9.99M Sell
743,441
-74,041
-9% -$995K 0.01% 1445
2015
Q3
$11.5M Sell
817,482
-445,542
-35% -$6.25M 0.01% 1352
2015
Q2
$21.4M Sell
1,263,024
-164,973
-12% -$2.8M 0.01% 966
2015
Q1
$17.3M Sell
1,427,997
-38,712
-3% -$468K 0.01% 1095
2014
Q4
$12.2M Sell
1,466,709
-3,388
-0.2% -$28.1K 0.01% 1342
2014
Q3
$12.8M Sell
1,470,097
-262,484
-15% -$2.28M 0.01% 1269
2014
Q2
$19M Sell
1,732,581
-124,770
-7% -$1.37M 0.01% 1061
2014
Q1
$16.6M Sell
1,857,351
-122,726
-6% -$1.1M 0.01% 1134
2013
Q4
$14.9M Buy
1,980,077
+1,182,725
+148% +$8.92M 0.01% 1203
2013
Q3
$5.85M Sell
797,352
-94,770
-11% -$695K ﹤0.01% 1837
2013
Q2
$5.74M Buy
+892,122
New +$5.74M ﹤0.01% 1803